SAI Life Sciences Ltd. (SAILIFE) Financial Statements

6 Followers

SAI Life Sciences Ltd. Financial Overview

SAI Life Sciences Ltd.'s market cap is currently ₹241.96B. The company's EPS TTM is ₹4.01; its P/E ratio is 58.36; SAI Life Sciences Ltd. is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 25
Income Statement
Total Revenue	₹ 16.96B	₹ 21.92B
Gross Profit	₹ 6.19B	₹ 7.72B
Operating Income	₹ 2.73B	₹ 4.64B
EBITDA	₹ 4.42B	₹ 6.31B
Net Income	₹ 1.70B	₹ 3.49B
Balance Sheet
Cash & Short-Term Investments	₹ 3.72B	₹ 1.58B
Total Assets	₹ 31.60B	₹ 36.26B
Total Debt	₹ 3.52B	₹ 2.88B
Net Debt	₹ 2.61B	₹ 1.78B
Total Liabilities	₹ 10.32B	₹ 11.42B
Stockholders' Equity	₹ 21.28B	₹ 24.84B
Cash Flow
Free Cash Flow	₹ -918.36M	₹ -721.30M
Operating Cash Flow	₹ 2.77B	₹ 5.21B
Investing Cash Flow	₹ -5.53B	₹ -4.18B
Financing Cash Flow	₹ 3.54B	₹ -1.13B

Currency in INR

SAI Life Sciences Ltd. Earnings and Revenue History

Income Statement >

SAI Life Sciences Ltd. Debt to Assets

Balance Sheet >

SAI Life Sciences Ltd. Cash Flow

Cash Flow >

SAI Life Sciences Ltd. Forecast EPS vs Actual EPS

Earnings >